Rajesh Malik - 10 May 2021 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Chief Medical Officer
Signature
/s/ James Stillman Hanson, attorney-in-fact
Issuer symbol
GTHX
Transactions as of
10 May 2021
Transactions value $
$3,000
Form type
4
Filing time
11 May 2021, 16:23:55 UTC
Next filing
30 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Options Exercise $3,000 +10,000 +23% $0.3 53,300 10 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Option (Right to Buy) Options Exercise $0 -10,000 -13% $0 65,000 10 May 2021 Common Stock 10,000 $0.3 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 42,300 shares of common stock and 11,000 restricted stock units
F2 All shares underlying this option have vested.